Pediatric Vaccines Market Size, Trends, Opportunities & Growth Analysis 2027

-
Pediatric Vaccines Market
Pediatric Vaccines Market

Vaccination is necessary for newborns to be protected against diseases such as pneumonia, polio, and influenza. Vaccination imitates a specific pathogen (infection-causing organism) and stimulates the immune system to make antibodies that develop resistance to diseases caused by these pathogens in the future.

The global Pediatric Vaccines Market is predicted to reach US$ 98,859 million by the end of 2027, with a value of US$ 37,567 million in 2019. The high cost of paediatric vaccines is likely to stifle the global market for paediatric vaccines. Many vaccines are exclusively available from one or two companies. Due to the large expenditure required to manufacture a vaccine, there are generally fewer providers for newer vaccinations. As a result, the price of vaccines rises. Furthermore, the market's expansion is projected to be hampered by vaccination accessibility in rural areas. According to the World Health Organization, around 19.4 million infants under the age of one year were not given essential immunizations in 2018.

The worldwide Pediatric Vaccines Market is likely to develop at a faster rate over the forecast period as people become more aware about vaccinations and immunisation. In the United States, for example, January is Cervical Health Awareness Month, during which the need of regular immunisation and screening in the prevention of cancer is promoted. Furthermore, rising instances of invasive cervical cancer are likely to enhance market growth. Cervical cancer can be avoided by getting vaccinated against HPV and having regular cervical checkups. According to the American Cancer Society, around 13,800 new instances of invasive cervical cancer are predicted to be diagnosed in the United States in 2020, with 4,290 women dying from the disease.

The market is growing due to the increased participation of government and non-government groups in promoting Pediatric Vaccines Market. For example, in December 2019, the World Health Organization certified Pneumosil, a third pneumococcal conjugate vaccine produced by India's Serum Institute. The Bill and Melinda Gates Foundation helped fund the project. Multivalent vaccinations are becoming increasingly popular on the market. For example, in December 2019, University of Nottingham researchers published a study that could lead to a better vaccination to defend against the bacterium Neisseria meningitides, which causes sepsis and meningitis. Multivalent vaccines are also important in protecting against altered strains, according to the study.

Comments

Post a Comment

Popular posts from this blog

Security Robot Market to Reach US$ 11.8 Billion by 2022

-
Image
Security Robot Market The Global Security Robot Market is estimated to be valued at US$ 11.8 billion in 2022 and is expected to exhibit a CAGR of 12.87% over the forecast period 2022 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: Security robots are rapidly gaining traction due to their ability to enhance security and surveillance in various industries. These robots offer advantages such as round-the-clock monitoring, real-time video monitoring, and quick response to potential threats. The increasing need for advanced security measures to prevent theft, vandalism, and unauthorized access is driving the demand for security robots. These robots are widely used in industries such as retail, healthcare, transportation, and manufacturing to ensure the safety of assets and individuals. The market is expected to witness significant growth due to the rising security concerns and advancements in robotic technologies. Market Key Trends: One ke
Read more

Intravenous Fluid Therapy is the Fastest Growing Segment Fueling the Growth of Intravenous Solutions Market

-
Image
Intravenous Solutions Market The global Intravenous Solutions Market is estimated to be valued at US$ 577,228 bn or Million in 2023 and is expected to exhibit a CAGR of 6.1% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: Intravenous solutions are fluids administered through a vein via a needle or catheter. They are often used to provide essential nutrients, medications, or fluids to patients. Common uses include rehydration, correcting electrolyte imbalances, and ensuring nutrition is delivered for patients who cannot eat or absorb nutrients through the digestive system. Market key trends: One of the major trends in the intravenous solutions market is the increasing use of intravenous fluid therapy. Intravenous fluid therapy involves the administration of aqueous solutions containing electrolytes, sugars, and medications through an intravenous catheter. It is widely used for rehydration, maintenance of f
Read more

Global Report on LED Driver Market for the Forecast Period 2023-2030

-
Image
LED Driver Market The LED Driver Market has been growing rapidly over the past few years, driven by the increasing demand for energy-efficient lighting solutions across residential, commercial, and industrial sectors. LED (light-emitting diode) lighting technology has several advantages over traditional lighting solutions such as incandescent and fluorescent lights, including longer lifespan, lower energy consumption, and lower maintenance costs. However, to power and control LED lights, an LED driver is required. The LED Driver Market was valued at USD 7.7 billion in 2020 and is expected to reach USD 10.5 billion by 2025, at a CAGR of 6.4% during the forecast period. LED drivers are electronic devices that regulate the power supply to LED lights. They convert AC voltage from a power source to DC voltage suitable for LEDs, and also provide the necessary current and voltage regulation to ensure proper functioning of the LED lights. LED drivers can be either constant current or constant
Read more